Next-Generation Sequencing (NGS) In Precision Medicine Global Market Report 2025

Description

Next-generation sequencing (NGS) in precision medicine refers to a cutting-edge genomic technology that allows rapid and comprehensive analysis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequences at exceptional scale and speed, providing insights far beyond those offered by traditional sequencing approaches. It plays a central role in precision medicine by revealing detailed information on individual genetic variations and molecular profiles, supporting highly informed medical assessments and decisions.

The primary types of products and services in next-generation sequencing (NGS) in precision medicine include sequencing instruments, consumables and reagents, library preparation kits, bioinformatics software, and NGS services. Sequencing instruments are specialized devices used to decode the DNA or RNA sequences of biological samples. Technologies covered include whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, RNA sequencing, and single-cell sequencing. NGS is applied in fields such as oncology, infectious diseases, rare and inherited disorders, prenatal and reproductive health, and pharmacogenomics. Key end users include hospitals and clinics, academic and research institutions, biopharmaceutical companies, diagnostic laboratories, and contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The next-generation sequencing (NGS) in precision medicine market research report is one of a series of new reports from The Business Research Company that provides next-generation sequencing (NGS) in precision medicine market statistics, including next-generation sequencing (NGS) in precision medicine industry global market size, regional shares, competitors with a next-generation sequencing (NGS) in precision medicine market share, detailed next-generation sequencing (NGS) in precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing (NGS) in precision medicine industry. This next-generation sequencing (NGS) in precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation sequencing (NGS) in precision medicine market size has grown rapidly in recent years. It will grow from $5.47 billion in 2024 to $6.42 billion in 2025 at a compound annual growth rate (CAGR) of 17.3%. The growth observed during the historic period can be linked to increased government investment in genomics research, rising incidence of genetic disorders, expansion of national biobank initiatives, growing demand for targeted therapies and biomarker discovery, and the emergence of multi-omics platforms.

The next-generation sequencing (NGS) in precision medicine market size is expected to see rapid growth in the next few years. It will grow to $12.03 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth projected for the forecast period can be attributed to rising demand for personalized medicine, broader applications beyond human genomics, increasing prevalence of cancer, expansion into non-communicable disease detection, and greater awareness and accessibility of genetic testing. Key trends during the forecast period include integration with next-generation sequencing, AI-enabled bioinformatics pipelines, incorporation of advanced imaging for improved diagnostics and treatment, innovations in sequencing chemistry, and the development of cloud-based bioinformatics solutions.

The increasing incidence of genetic disorders is expected to drive the growth of the next-generation sequencing (NGS) market in precision medicine. Genetic disorders are conditions caused by abnormalities in an individual's DNA, which can be inherited or result from mutations. Advances in diagnostic technologies, such as genetic screening and next-generation sequencing, have improved the ability to detect genetic disorders, leading to a higher reported prevalence. NGS plays a vital role in precision medicine by identifying genetic mutations, enabling accurate diagnoses, personalized treatments, and early interventions. For example, in May 2024, the National Health Service in the UK reported that around 17,000 people in England live with sickle cell disease, a genetic blood disorder, with approximately 250 new cases diagnosed annually. As the incidence of genetic disorders continues to rise, the demand for NGS in precision medicine is increasing.

Companies operating in the NGS precision medicine market are focusing on innovative solutions, such as multimodal DNA and RNA library kits, to improve the efficiency and accuracy of genomic analyses. These kits enable the simultaneous preparation of sequencing libraries from both DNA and RNA within a single workflow, allowing for comprehensive analysis of a sample's genome and transcriptome. For instance, in May 2024, Qiagen N.V., a Germany-based provider of sample and assay technologies, launched the QIAseq Multimodal DNA and RNA Library Kit. This NGS solution supports multiomic studies by streamlining DNA and RNA library preparation from a single sample, reducing the need for large amounts of material and labor-intensive procedures associated with traditional separate workflows. By enhancing the efficiency of multiomic research, this kit supports precision medicine advancements, particularly in cancer research, by facilitating better biomarker discovery and disease understanding.

In June 2025, Qiagen N.V. partnered with Incyte Corporation, a U.S.-based biopharmaceutical company, to develop a multimodal NGS companion diagnostic panel for patients with myeloproliferative neoplasms (MPNs). This collaboration aims to create a diagnostic tool that identifies mutations in CALR and other genes associated with MPNs, helping guide patient selection for targeted therapies and improving treatment outcomes. By advancing precision medicine, this partnership supports the development of more effective treatments for MPN patients.

Major players in the next-generation sequencing (NGS) in precision medicine market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Natera Inc., Tempus Labs Inc., 10x Genomics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Fulgent Genetics Inc., Twist Bioscience Corporation, Pacific Biosciences of California Inc., Macrogen Inc., Ultima Genomics Inc., Personalis Inc., Element Biosciences Inc., Genomenon Inc., Strand Life Sciences Pvt. Ltd., and Singular Genomics Systems Inc.

North America was the largest region in the next-generation sequencing (NGS) in precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next-generation sequencing (NGS) in precision medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the next-generation sequencing (NGS) in precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The next-generation sequencing (NGS) in precision medicine market consists of revenues earned by entities by providing services such as whole genome sequencing, metagenomic sequencing, hereditary cancer screening, pharmacogenomics testing, and rare disease diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation sequencing (NGS) in precision medicine market also includes sales of sequencing instruments, reagents and consumables, bioinformatics software, data analysis tools, and sequencing panels and assays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Sequencing (NGS) In Precision Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next-generation sequencing (ngs) in precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation sequencing (ngs) in precision medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation sequencing (ngs) in precision medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product And Service: Sequencing Instruments; Consumables And Reagents; Library Preparation Kits; Bioinformatics Software; Next-Generation Sequencing (NGS) Services
2) By Technology: Whole Genome Sequencing (WGS); Whole Exome Sequencing (Wes); Targeted Sequencing; Ribonucleic Acid (RNA) Sequencing; Single-Cell Sequencing
3) By Application: Oncology; Infectious Disease; Rare And Inherited Disorders; Prenatal And Reproductive Health; Pharmacogenomics
4) By End Use: Hospitals And Clinics; Academic And Research Institutions; Biopharmaceutical Companies; Diagnostic Laboratories; Contract Research Organizations (CROs)
Subsegments:
1) By Sequencing Instruments: Benchtop Sequencers; High Throughput Sequencers; Portable Sequencers
2) By Consumables And Reagents: Sequencing Reagents; Sequencing Chips; Flow Cells; Sample Preparation Reagents
3) By Library Preparation Kits: Deoxyribonucleic Acid (DNA) Library Preparation Kits; Ribonucleic Acid (RNA) Library Preparation Kits; Whole Genome Amplification Kits; Target Enrichment Kits
4) By Bioinformatics Software: Data Analysis Software; Data Management Software; Sequence Alignment Software; Variant Calling Software
5) By Next-Generation Sequencing Services: Whole Genome Sequencing Services; Whole Exome Sequencing Services; Targeted Sequencing Services; Ribonucleic Acid (RNA) Sequencing Services; Epigenomic Sequencing Services
Companies Mentioned: Thermo Fisher Scientific Inc.; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; Exact Sciences Corporation; QIAGEN N.V.; Natera Inc.; Tempus Labs Inc.; 10x Genomics Inc.; BGI Genomics Co. Ltd.; Guardant Health Inc.; Caris Life Sciences Inc.; Fulgent Genetics Inc.; Twist Bioscience Corporation; Pacific Biosciences of California Inc.; Macrogen Inc.; Ultima Genomics Inc.; Personalis Inc.; Element Biosciences Inc.; Genomenon Inc.; Strand Life Sciences Pvt. Ltd.; Singular Genomics Systems Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r38586

1. Executive Summary

2. Next-Generation Sequencing (NGS) In Precision Medicine Market Characteristics

3. Next-Generation Sequencing (NGS) In Precision Medicine Market Trends And Strategies

4. Next-Generation Sequencing (NGS) In Precision Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Next-Generation Sequencing (NGS) In Precision Medicine Growth Analysis And Strategic Analysis Framework

5.1. Global Next-Generation Sequencing (NGS) In Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Next-Generation Sequencing (NGS) In Precision Medicine Market Growth Rate Analysis
5.4. Global Next-Generation Sequencing (NGS) In Precision Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Next-Generation Sequencing (NGS) In Precision Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Next-Generation Sequencing (NGS) In Precision Medicine Total Addressable Market (TAM)

6. Next-Generation Sequencing (NGS) In Precision Medicine Market Segmentation

6.1. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencing Instruments
Consumables And Reagents
Library Preparation Kits
Bioinformatics Software
Next-Generation Sequencing (NGS) Services
6.2. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (Wes)
Targeted Sequencing
Ribonucleic Acid (RNA) Sequencing
Single-Cell Sequencing
6.3. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Infectious Disease
Rare And Inherited Disorders
Prenatal And Reproductive Health
Pharmacogenomics
6.4. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Academic And Research Institutions
Biopharmaceutical Companies
Diagnostic Laboratories
Contract Research Organizations (CROs)
6.5. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Sequencing Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Benchtop Sequencers
High Throughput Sequencers
Portable Sequencers
6.6. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Consumables And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencing Reagents
Sequencing Chips
Flow Cells
Sample Preparation Reagents
6.7. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Library Preparation Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deoxyribonucleic Acid (DNA) Library Preparation Kits
Ribonucleic Acid (RNA) Library Preparation Kits
Whole Genome Amplification Kits
Target Enrichment Kits
6.8. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Bioinformatics Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis Software
Data Management Software
Sequence Alignment Software
Variant Calling Software
6.9. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Sub-Segmentation Of Next-Generation Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole Genome Sequencing Services
Whole Exome Sequencing Services
Targeted Sequencing Services
Ribonucleic Acid (RNA) Sequencing Services
Epigenomic Sequencing Services

7. Next-Generation Sequencing (NGS) In Precision Medicine Market Regional And Country Analysis

7.1. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Next-Generation Sequencing (NGS) In Precision Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market

8.1. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next-Generation Sequencing (NGS) In Precision Medicine Market

9.1. China Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
9.2. China Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next-Generation Sequencing (NGS) In Precision Medicine Market

10.1. India Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market

11.1. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
11.2. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next-Generation Sequencing (NGS) In Precision Medicine Market

12.1. Australia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next-Generation Sequencing (NGS) In Precision Medicine Market

13.1. Indonesia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market

14.1. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
14.2. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market

15.1. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
15.2. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next-Generation Sequencing (NGS) In Precision Medicine Market

16.1. UK Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next-Generation Sequencing (NGS) In Precision Medicine Market

17.1. Germany Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next-Generation Sequencing (NGS) In Precision Medicine Market

18.1. France Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next-Generation Sequencing (NGS) In Precision Medicine Market

19.1. Italy Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next-Generation Sequencing (NGS) In Precision Medicine Market

20.1. Spain Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market

21.1. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
21.2. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next-Generation Sequencing (NGS) In Precision Medicine Market

22.1. Russia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next-Generation Sequencing (NGS) In Precision Medicine Market

23.1. North America Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
23.2. North America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next-Generation Sequencing (NGS) In Precision Medicine Market

24.1. USA Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
24.2. USA Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market

25.1. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
25.2. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next-Generation Sequencing (NGS) In Precision Medicine Market

26.1. South America Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
26.2. South America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next-Generation Sequencing (NGS) In Precision Medicine Market

27.1. Brazil Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market

28.1. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
28.2. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market

29.1. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market Overview
29.2. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Next-Generation Sequencing (NGS) In Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next-Generation Sequencing (NGS) In Precision Medicine Market Competitive Landscape And Company Profiles

30.1. Next-Generation Sequencing (NGS) In Precision Medicine Market Competitive Landscape
30.2. Next-Generation Sequencing (NGS) In Precision Medicine Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Next-Generation Sequencing (NGS) In Precision Medicine Market Other Major And Innovative Companies

31.1. Exact Sciences Corporation
31.2. QIAGEN N.V.
31.3. Natera Inc.
31.4. Tempus Labs Inc.
31.5. 10x Genomics Inc.
31.6. BGI Genomics Co. Ltd.
31.7. Guardant Health Inc.
31.8. Caris Life Sciences Inc.
31.9. Fulgent Genetics Inc.
31.10. Twist Bioscience Corporation
31.11. Pacific Biosciences of California Inc.
31.12. Macrogen Inc.
31.13. Ultima Genomics Inc.
31.14. Personalis Inc.
31.15. Element Biosciences Inc.

32. Global Next-Generation Sequencing (NGS) In Precision Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next-Generation Sequencing (NGS) In Precision Medicine Market

34. Recent Developments In The Next-Generation Sequencing (NGS) In Precision Medicine Market

35. Next-Generation Sequencing (NGS) In Precision Medicine Market High Potential Countries, Segments and Strategies

35.1 Next-Generation Sequencing (NGS) In Precision Medicine Market In 2029 - Countries Offering Most New Opportunities
35.2 Next-Generation Sequencing (NGS) In Precision Medicine Market In 2029 - Segments Offering Most New Opportunities
35.3 Next-Generation Sequencing (NGS) In Precision Medicine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer